Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001059955 | SCV001224610 | pathogenic | Cerebral creatine deficiency syndrome | 2023-12-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp101Thrfs*13) in the GAMT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAMT are known to be pathogenic (PMID: 15108290). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GAMT-related conditions. ClinVar contains an entry for this variant (Variation ID: 854826). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003467804 | SCV004198603 | likely pathogenic | Deficiency of guanidinoacetate methyltransferase | 2024-01-16 | criteria provided, single submitter | clinical testing |